Resources

For over a decade, Cognizant’s Shared Investigator Platform (SIP) has transformed global clinical research, evolving from a bold vision into a trusted solution that connects thousands of sponsors, sites, and investigators. Today, SIP continues to streamline collaboration, accelerate trials, and enhance transparency to deliver better patient outcomes.

Clinical research continues to evolve toward greater connectivity and efficiency, yet study startup remains one of the most complex and time-consuming stages of a trial. Disjointed systems and communication gaps between sponsors, CROs, and research sites often lead to avoidable delays. To address these challenges, Advarra...

“It’s incredibly frustrating […] we want technology that actually improves their job”. This was shared in a recent Site Listening Session, but it’s a sentiment I’m sure many can relate to. When tools that are intended to support and accelerate are delivered without their users in mind, it’s a recipe for failure. For sites, every redundant training, missed integration opportunity, and feature that doesn’t quite work as it should, ticks away at the time that could be better spent with patients.

The landscape of oncology clinical research is rapidly evolving with the emergence of radiopharmaceutical therapies, also known as radioligand therapy (RLT). These innovative treatments represent a precision medicine approach that uses targeted radiation to treat cancer with a goal of minimizing damage to healthy tissue. However,

Direct-to-patient clinical trials are removing traditional barriers to research participation by bringing study activities into patients' homes. Through partnerships that combine virtual site operations with global medication delivery, trials can now reach more diverse populations while reducing travel burdens and accelerating enrollment. Read on to learn how Science 37 and Catalent are making this possible.

Cognizant, in collaboration with research KOLs from Australia, delves into the impact of Teletrials in Australia and how these hybrid, decentralized model of trials are bringing novel therapies closer to regional, rural and remote Australians. Teletrials promise to be a global case study on how public health can be promoted at a national level. Download this insightful publication and learn about the steps being taken by Australian Teletrial Program (ATP) to promote teletrials, point of view from Cognizant on how intelligent tech and process alignment can further enhance efficacy of teletrials and real world use cases of teletrials.

With 80% of trials failing to recruit enough patients and an explosion of recruitment vendors, how do you choose the right partner? This framework breaks down the landscape, from creative agencies to AI-driven technology, and reveals why success depends on understanding patient motivation, not just operations. Read on to discover how to select strategies that build trust and remove barriers.

Sites juggle multiple studies and endless questions, but the clear guidance they need often lags behind. Explore why timely answers and stronger communication are essential to keeping trials running smoothly.

Sales in clinical research isn't about convincing, it's about connecting. The most successful organizations don't have bigger sales teams; they have cultures where everyone contributes to growth. What does it mean when your entire team becomes your "hidden sales force"? Read on to discover why the best organizations don't sell harder — they lead better.

Site operations costs are escalating, but AI offers an unprecedented opportunity to transform financial management in clinical research. From faster budget negotiations to automated reconciliation, AI can address the pain points that burden sites and sponsors. Read on to discover how this technology revolution is reshaping the financial landscape of clinical trials.

The FDA has lifted REMS requirements for all approved CAR-T therapies, a move that could transform access for patients and research sites alike. What does this mean for trial participation, site activation, and the future of cell and gene therapy? Read on to see how this shift reshapes the CAR-T landscape.

Data entry continues to be one of the biggest sources of burden for sites. Electronic Health Record (EHR) to Electronic Data Capture (EDC) data transfer technology is a leading example of how sponsors, sites, and vendors are collaborating as an ecosystem to reduce the data entry bottleneck in clinical trial operations.

Improving the patient experience in clinical trials starts with supporting sites. Learn why Sponsors must prioritize the site experience to deliver better outcomes for patients and better results for the study.

Participant compensation is a critical factor in clinical trials, directly influencing trust, retention, and overall study success. Explore approaches that adapt to diverse needs, enhance experiences, and reduce operational strain, ensuring trials run efficiently while maintaining credibility and participant satisfaction.

Clinical research is no easy feat — balancing science, regulations, operations, and people is a high-stakes challenge. At the center of it all is the protocol, our guiding document. But more often than not, translating that protocol into real-world action feels like decoding a Rosetta Stone. After reviewing more than 1,250 protocols, ProofPilot's Senior Clinical Program Manager, Kathryn Gentz, has identified six common mistakes that lead to confusion, deviations, and unnecessary costs. Here’s what to watch out for.